Tell Ulcerative Colitis Patients Entyvio Doesn't Seem to Cause Immunosuppression

June 2015

Entyvio (en-TIH-vee-oh, vedolizumab) is a new biologic option for treating ulcerative colitis in adults....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Diabetes Don't Use a One-Size- Fits-All Approach for Diabetes Add-On Meds
NSAIDs Recommend Lower Ibuprofen Doses for Patients With Diabetes Recommend NOT Using
Women s Health Explain When Backup Contraception is NOT Needed with Antibiotics
Hypertension Recommend a Beta-Blocker in Coronary Artery Disease Patients with Hypertension
Constipation Don't Count on Stool Softeners for Opioid-Induced Constipation
Substance Use Disorder Use a Teach-Back Approach When Counselling Teens About Med Use
ADHD Ensure Males Are Informed About Priapism Risk With Methylphenidate
Gastroenterology Tell Ulcerative Colitis Patients Entyvio Doesn't Seem to Cause Immunosuppression
Sunscreens Recommend Reapplying Sunscreen at Least Every 2 Hours
Infectious Diseases Recommend a Beta-Lactam/Macrolide Combo in Hospitalized Pneumonia Patients
Interactions Caution Not to Use Sofosbuvir Antiviral Regimens With Amiodarone
Days Supply Call for Clarification Over Reject Messages for Eye and Ear Drops
Alcohol Help People Understand the New Powdered Alcohol "Drink"